Comparing Predictability of Non-invasive Tools for Hepatocellular Carcinoma in Treated Chronic Hepatitis C Patients

[11] Barclay ST(2017)Comparing child-Pugh, MELD, and FIB-4 to predict clinical outcomes in hepatitis C virus-infected persons: results from ERCHIVES Clin Infect Dis 65 656-663

[12] Moon AM(2011)Liver stiffness diminishes with antiviral response in chronic hepatitis C Aliment Pharmacol Ther. 34 1821-752

[13] Green PK(2015)Regression of liver stiffness after sustained hepatitis C virus (HCV) virological responses among HIV/HCV-coinfected patients AIDS (London, England) 29 743-143

[14] Rockey DC(2015)Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension J. Hepatol. 63 137-1799

[15] Berry K(2014)Prediction of liver stiffness hepatocellular carcinoma in chronic hepatitis C patients on interferon-based anti-viral therapy Journal of Gastroenterology and Hepatology 29 1793-3019

[16] Ioannou GN(2016)Liver stiffness-based score in hepatoma risk assessment for chronic hepatitis C patients after successful antiviral therapy Liver International 36 429-1265

[17] Ioannou GN(2016)Predicting liver-related events using transient elastography in chronic hepatitis C patients with sustained virological response Gut Liver 10 3013-1543

[18] Pons M(2019)Factors associated with increased risk of de novo or recurrent hepatocellular carcinoma in patients with cirrhosis treated with direct-acting antivirals for HCV infection Clinical Gastroenterology and Hepatology 17 1257-1021

[19] Rodríguez-Tajes S(2019)Role of liver stiffness measurement in predicting HCC occurrence in direct-acting antivirals setting: a real-life experience Digestive Diseases and Sciences 64 0243725-579

[20] Esteban JI(2019)Liver steatosis is a major predictor of poor outcomes in chronic hepatitis C patients with sustained virological response Journal of Viral Hepatitis 26 1536-2746

[11] Barclay ST(2017)Comparing child-Pugh, MELD, and FIB-4 to predict clinical outcomes in hepatitis C virus-infected persons: results from ERCHIVES Clin Infect Dis 65 656-663

[12] Moon AM(2011)Liver stiffness diminishes with antiviral response in chronic hepatitis C Aliment Pharmacol Ther. 34 1821-752

[13] Green PK(2015)Regression of liver stiffness after sustained hepatitis C virus (HCV) virological responses among HIV/HCV-coinfected patients AIDS (London, England) 29 743-143

[14] Rockey DC(2015)Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension J. Hepatol. 63 137-1799

[15] Berry K(2014)Prediction of liver stiffness hepatocellular carcinoma in chronic hepatitis C patients on interferon-based anti-viral therapy Journal of Gastroenterology and Hepatology 29 1793-3019

[16] Ioannou GN(2016)Liver stiffness-based score in hepatoma risk assessment for chronic hepatitis C patients after successful antiviral therapy Liver International 36 429-1265

[17] Ioannou GN(2016)Predicting liver-related events using transient elastography in chronic hepatitis C patients with sustained virological response Gut Liver 10 3013-1543

[18] Pons M(2019)Factors associated with increased risk of de novo or recurrent hepatocellular carcinoma in patients with cirrhosis treated with direct-acting antivirals for HCV infection Clinical Gastroenterology and Hepatology 17 1257-1021

[19] Rodríguez-Tajes S(2019)Role of liver stiffness measurement in predicting HCC occurrence in direct-acting antivirals setting: a real-life experience Digestive Diseases and Sciences 64 0243725-579

[20] Esteban JI(2019)Liver steatosis is a major predictor of poor outcomes in chronic hepatitis C patients with sustained virological response Journal of Viral Hepatitis 26 1536-2746